The company is outgrowing its own explanations: management keeps telling investors the reported numbers are not the busi
The model's full reasoning — Q2 2017 call → NOWe need to determine if management conveys that the reported results do not represent the business actually running today, i.e., the period is stale relative to the operating present. The transcript is from Q2 2017 earnings call. Management discusses results, growth, margins, dividend increase, etc. They note improvements in revenue growth acceleration, sales rep productivity at record highs, and they express optimism for remainder of 2017. They also mention that they added sales reps, have highest number in history. They talk about NetCentric revenue growth improving from 3.8% to 6.1% constant currency. They talk about future expectations of 10-20% growth and margin expansion. But do they explicitly say that the reported quarter does not reflect current business? They mention that the quarter's results were encouraging, but no indication that the business has changed dramatically since the quarter ended. They talk about ongoing trends, but nothing like "the results we just reported are stale because we have already moved to a different level." They do mention that they have record salesforce productivity, highest number of reps, but that is within the quarter. They also mention that they are adding buildings, etc., but that is normal. There's no explicit statement that the current business is ahead of the reported period. They also mention that they have increased dividend, but that's forward-looking. The question asks if management repeatedly or substantially indicates that the just-reported numbers describe a company that has already been left behind by what is now actually happening inside the business. The tone is positive, but it's a standard results and outlook. No specific gap is highlighted. They talk about improved trends, but not that the period underreports the current level. So answer NO. Answer: NO
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
VRE · Q4 2022 → YESThe question is: Does management convey that the reported results for the period do not represent the business the company is actually running today? That the just-reported numbers describe a company ...YES The transcript shows management repeatedly framing the reported period as transitional and not reflective of the current business: the shift to a pure-play multi-family company has already reduced office and hotel exposure while driving multi-family NOI share to 98%, with Haus25 leased at 95% ahead of schedule and same-store NOI guidance of 4-6% for 2023. They explicitly note that earnings variability stems from the ongoing asset sales and reallocation, with the business now positioned for growth as the transformation concludes, and they highlight post-period activity like additional sales and stabilized properties to underscore that the reported numbers capture a pre-transition state.
PFE · Q4 2023 → YESThe question is: Does management convey that the reported results do not represent the business the company is actually running today? That the just-reported numbers describe a company that has alread...NO The transcript shows management framing 2023 results as a challenging year with declines driven by COVID products, while positioning 2024 as a year of execution and growth through new priorities like the Seagen acquisition (closed late in 2023 with minimal contribution) and new product launches. This is a standard results-and 2024 outlook discussion, with forward-looking elements on pipeline, margins, and capital allocation rather than indicating the reported period is stale relative to current operations.
PRIM · Q2 2018 → YESThe question is whether management conveys that the reported results for Q2 2018 do not represent the business the company is actually running today. Specifically, if the printed period is stale relat...YES The transcript shows management repeatedly framing the Q2 results as a partial picture due to the late June 1 acquisition of Willbros. They note the business is "running as planned," highlight one-month revenue contribution of $1.